{
  "id" : "extension_bfg",
  "algorithm" : "eod_public",
  "version" : "3.2",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** **In-situ and HAMN** \n* Code 000 (behavior code 2) includes cancer cells confined within the glandular basement membrane (intraepithelial) or described as in situ or high-grade appendiceal mucinous neoplasms (HAMN)\n\n**Note 2:** **LAMN** \n* Code 050 (behavior code 2) for low-grade appendiceal mucinous neoplasms (LAMN) that are confined by the muscularis propria.\n* See codes 350-750 for LAMN tumors that extend beyond the muscularis propria \n\n**Note 3:** **Code 070 (behavior code 3)**\n* Intramucosal, NOS\n* Lamina propria\n* Mucosa, NOS\n* Confined to, but not through the muscularis mucosa\n\n**Note 4:** **Intraluminal extension** \n* Ignore intraluminal extension to adjacent segment(s) of colon/rectum or to the ileum from the cecum; code depth of invasion or extracolonic spread as indicated.\n\n**Note 5:** **Mucinous Tumors** \n* Mucinous tumors are identified by morphology codes 8480, 8481, and 8490.\n\n**Note 6:** **Invasion of subserosa or mesoappendix** \n* Code 300 when the only statement is \"Tumor invades through the muscularis propria into subserosa or mesoappendix but does not extend to serosal surface\" and there isn't enough information to clarify subserosa versus mesoappendix. \n\n**Note 7:** **Macroscopic adhesions** \n* Use code 700 for macroscopic adhesions if no pathological confirmation, and for microscopically confirmed tumor in adhesions. \n* However, if no tumor is present in adhesion(s) upon microscopic examination, the classification is based upon extent of tumor invasion into or through the wall (see codes 100-600). \n\n**Note 8:** **Contiguous extension** \n* Codes 700 and 750 are used for contiguous extension from the site of origin\n* Except for intraperitoneal metastases limited to the right lower quadrant (RLQ) of the abdomen for **mucinous tumors (see code 600)**, **discontinuous involvement is coded in EOD Mets**.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Overman, M.J., Jessup, J.M., et al. **Appendix - Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017",
  "last_modified" : "2024-04-24T20:47:41.296Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_t",
    "name" : "EOD 2018 T",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ, intraepithelial, noninvasive \n(Adeno) carcinoma, noninvasive, in a polyp or adenoma\n\nHigh-grade appendiceal mucinous neoplasm confined by the muscularis propria (HAMN)", "VALUE:Tis", "VALUE:IS" ], [ "050", "Low-grade appendiceal mucinous neoplasm confined by the muscularis propria (LAMN) (in situ)\n\nAcellular mucin or mucinous epithelium may invade into muscularis propria", "VALUE:Tis(LAMN)", "VALUE:IS" ], [ "070", "Lamina propria\nMucosa (intramucosal, NOS)\nMuscularis mucosae", "VALUE:Tis", "VALUE:L" ], [ "100", "Submucosa\n\nConfined to appendix, NOS\nConfined to polyp, NOS\nLocalized, NOS", "VALUE:T1", "VALUE:L" ], [ "200", "Muscularis propria", "VALUE:T2", "VALUE:L" ], [ "300", "Extension through wall, NOS\nInvasion through muscularis propria\nNon-peritonealized pericolic tissues invaded\nPerimuscular tissue invaded\nSubserosa \n* Includes acellular mucin or mucinous epithelium that extends into the subserosa (LAMN tumors)\n\nTransmural, NOS\nWall, NOS", "VALUE:T3", "VALUE:L" ], [ "400", "Adjacent tissue(s), NOS\nConnective tissue\nFat, NOS\nMesenteric fat\nMesentery \nMesoappendix\n* Includes acellular mucin or mucinous epithelium that extends into the mesoappendix (LAMN tumors)\n  * See code 500 if serosa of the mesoappendix is involved\n\nPericolic fat", "VALUE:T3", "VALUE:RE" ], [ "500", "Invasion of/through serosa (mesothelium) (visceral peritoneum)\n* Includes acellular mucin or mucinous epithelium involving the serosa of the appendix or serosa of the mesoappendix (LAMN tumors)", "VALUE:T4a", "VALUE:RE" ], [ "700", "Abdominal wall\nAdherent to other organs or structures\nGreater omentum\nRetroperitoneum (excluding fat)\nSmall intestine\n\nTumor found in adhesion(s) if microscopic examination performed", "VALUE:T4b", "VALUE:RE" ], [ "750", "Adrenal (suprarenal) gland\nBladder\nDiaphragm\nFallopian tube\nFistula to skin\nGallbladder\nKidney\nLiver\nOther segment(s) of colon/rectum via serosa\nOvary\nUreter\nUterus\n\nFurther contiguous extension", "VALUE:T4b", "VALUE:D" ], [ "800", "No evidence of primary tumor", "VALUE:T0", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in medical record\n\nDeath Certificate Only", "VALUE:TX", "VALUE:U" ] ]
}